Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase Ib: To determine RP2D and estimate MTD of LJM716 in combination with cetuximab in patients with RM HNSCC Phase II: To access the anti-tumor activity of LJM716-cetuximab combination in cetuximab naïve (Group A) and cetuximab pretreated (Group B) patients with RM HNSCC
Critère d'inclusion
- Head and neck squamous cell carcinoma